Fletcher Ws

658 total citations
38 papers, 518 citations indexed

About

Fletcher Ws is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Epidemiology. According to data from OpenAlex, Fletcher Ws has authored 38 papers receiving a total of 518 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Oncology, 7 papers in Pulmonary and Respiratory Medicine and 7 papers in Epidemiology. Recurrent topics in Fletcher Ws's work include Neuroendocrine Tumor Research Advances (5 papers), Radiopharmaceutical Chemistry and Applications (4 papers) and Estrogen and related hormone effects (4 papers). Fletcher Ws is often cited by papers focused on Neuroendocrine Tumor Research Advances (5 papers), Radiopharmaceutical Chemistry and Applications (4 papers) and Estrogen and related hormone effects (4 papers). Fletcher Ws collaborates with scholars based in United States and Canada. Fletcher Ws's co-authors include Metter Ge, Grage Tb, Weiss Aj, Ping Yein Lee, Kenneth R. Stevens, Michelle Harrison, Truman M. Sasaki, Krementz Et, Nealon Tf and Minton Jp and has published in prestigious journals such as PubMed and Munich Personal RePEc Archive (Ludwig Maximilian University of Munich).

In The Last Decade

Fletcher Ws

33 papers receiving 452 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Fletcher Ws United States	12	297	134	116	113	103	38	518
D. J. Richel Netherlands	17	313 1.1×	216 1.6×	45 0.4×	246 2.2×	72 0.7×	29	844
Felipe G. Gercovich Argentina	7	218 0.7×	101 0.8×	23 0.2×	52 0.5×	107 1.0×	29	439
Nassir Habboubi United States	7	223 0.8×	74 0.6×	68 0.6×	45 0.4×	60 0.6×	21	336
M Namer France	12	271 0.9×	116 0.9×	13 0.1×	55 0.5×	60 0.6×	36	442
Leo J. Ostruszka United States	7	209 0.7×	191 1.4×	59 0.5×	47 0.4×	48 0.5×	7	388
Papac Rj United States	6	139 0.5×	60 0.4×	16 0.1×	38 0.3×	38 0.4×	9	341
Mark Appleton United Kingdom	13	109 0.4×	69 0.5×	29 0.3×	217 1.9×	64 0.6×	17	479
R V Smalley United States	8	193 0.6×	52 0.4×	27 0.2×	29 0.3×	52 0.5×	13	321
Shuhei Inoue Japan	15	230 0.8×	327 2.4×	26 0.2×	146 1.3×	49 0.5×	63	688
Catherine Sarta United States	10	218 0.7×	66 0.5×	26 0.2×	60 0.5×	78 0.8×	15	395

Countries citing papers authored by Fletcher Ws

Since Specialization

Citations

This map shows the geographic impact of Fletcher Ws's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Fletcher Ws with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Fletcher Ws more than expected).

Fields of papers citing papers by Fletcher Ws

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Fletcher Ws. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Fletcher Ws. The network helps show where Fletcher Ws may publish in the future.

Co-authorship network of co-authors of Fletcher Ws

This figure shows the co-authorship network connecting the top 25 collaborators of Fletcher Ws. A scholar is included among the top collaborators of Fletcher Ws based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Fletcher Ws. Fletcher Ws is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

O’Dorisio, Thomas M., et al.. (1988). Suppression of primary and secondary peptides with somatostatin analog in the therapy of functional endocrine tumors.. PubMed. 167(6). 453–62. 7 indexed citations

Kopecky, Kenneth J., et al.. (1987). Phase II evaluation of spirogermanium in malignant melanoma: a Southwest Oncology Group Study.. PubMed. 71(10). 985–6. 1 indexed citations

Ws, Fletcher, et al.. (1986). Analysis of the risk reduction of prophylactic partial mastectomy in Sprague-Dawley rats with 7,12-dimethylbenzanthracene-induced breast cancer.. PubMed. 99(1). 67–71. 20 indexed citations

Lh, Baker, et al.. (1985). Phase II trial of diaziquone in advanced large bowel carcinoma in previously treated and untreated patients: a Southwest Oncology Group Study.. PubMed. 69(6). 709–10. 2 indexed citations

Peetz, Michael E., et al.. (1982). Endocrine ablation and hepatic artery infusion in the treatment of metastases to the liver from carcinoma of the breast.. PubMed. 155(3). 395–400. 7 indexed citations

Ws, Fletcher, et al.. (1981). Superior vena caval thrombosis as a complication of peritoneovenous shunt in malignancy.. PubMed. 47(9). 415–6. 3 indexed citations

Ge, Metter, et al.. (1980). DTIC and combination therapy for melanoma. II. Escalating schedules of DTIC with BCNU, CCNU, and vincristine.. PubMed. 63(11-12). 1989–92. 19 indexed citations

Aj, Weiss, et al.. (1977). Phase II study of 5-azacytidine in solid tumors.. PubMed. 61(1). 55–8. 38 indexed citations

Anderson, Donald D., et al.. (1976). Islet cell carcinoma of the pancreas: effective therapy with 5-fluorouracil, streptozotocin, and tubercidin.. Munich Personal RePEc Archive (Ludwig Maximilian University of Munich). 42(7). 467–70. 6 indexed citations

10.

Et, Krementz, et al.. (1976). DTIC (nsc-45388) and combination therapy for melanoma. I. Studies with DTIC, BCNU (NSC-409962), CCNU (NSC-79037), vincristine (NSC-67574), and hydroxyurea (NSC-32065).. PubMed. 60(5). 601–9. 28 indexed citations

11.

Metter, Gerald E., et al.. (1976). Multimodal surgical adjuvant therapy for a broad spectrum of tumors in humans.?. PubMed. 142(6). 882–92. 6 indexed citations

12.

Aj, Weiss, et al.. (1976). Studies on adriamycin using a weekly regimen demonstrating its clinical effectiveness and lack of cardiac toxicity.. PubMed. 60(7). 813–22. 110 indexed citations

13.

Ws, Fletcher, et al.. (1976). Therapeutic value of nafoxidine hydrochloride in the treatment of advanced carcinoma of the human breast.. PubMed. 142(4). 560–4. 3 indexed citations

14.

Ws, Fletcher, et al.. (1975). The importance of the canine species in biomedical research.. PubMed. 7(3). 341–2.

15.

Ws, Fletcher, et al.. (1972). Management of chylothorax secondary to lymphoma.. PubMed. 135(1). 35–8. 11 indexed citations

16.

Ws, Fletcher, et al.. (1972). Search for new cancer drugs: streptozotocin.. PubMed. 38(9). 514–20. 2 indexed citations

17.

Ws, Fletcher, et al.. (1968). Mesh wrapping in the treatment of abdominal aortic aneurysms: a preliminary report.. PubMed. 34(7). 470–8. 2 indexed citations

18.

Ws, Fletcher, et al.. (1966). Severe tumor pain with intravenous injection of vinblastine sulfate (NSC-49842).. PubMed. 50(5). 281–2. 1 indexed citations

19.

Ws, Fletcher, et al.. (1963). ENHANCEMENT OF THE THERAPEUTIC EFFECT OF STILBESTEROL ON EXPERIMENTAL BREAST CANCER.. PubMed. 14. 133–5. 1 indexed citations

20.

Ws, Fletcher, et al.. (1963). A CLINICAL STUDY OF PRIMARY CARCINOMA OF THE GALLBLADDER.. PubMed. 117. 297–300. 18 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact